The impact of myosteatosis on postoperative outcomes and survival of patients undergoing pancreatoduodenectomy for suspected/confirmed malignancy.

Paul Jenkins Andrew MacCormick Adam J Streeter Mark Puckett Gemma Miles Somaiah Aroori

Published in: Annals of hepato-biliary-pancreatic surgery (2024)

We have found no evidence supporting myosteatosis affecting either the short-term or long-term outcomes of patients undergoing PD for suspected/confirmed malignant tumors.

Keyphrases

patients undergoing
pulmonary embolism
type diabetes
adipose tissue
metabolic syndrome
skeletal muscle
insulin resistance
weight loss